呼吸吸入器市场按类型、产品、应用、最终用户和地区划分

2025 年全球呼吸吸入器市场规模估计为 351 亿美元，预计到 2032 年将达到 528.1 亿美元，2025 年至 2032 年的年复合成长率(CAGR)为 6.0%。

数字。 2025 年呼吸吸入器市场占有率（按地区划分）

呼吸吸入器是一种用于给药治疗气喘和慢性阻塞性肺病等呼吸系统疾病的医疗设备。这些有助于透过吸入将所需量的药量直接输送到呼吸道。由于环境因素导致的呼吸系统疾病盛行率上升、易患此类疾病的老年人口不断增加以及人们对吸入器治疗的认识不断提高，可能会推动市场成长。吸入器药物输送技术的进步、智慧和数位吸入器的发展以及功效更高的组合吸入器的推出也将推动市场成长。然而，高昂的治疗费用以及农村地区缺乏治疗机会可能会阻碍其广泛采用。

市场动态

全球呼吸吸入器市场的成长主要受到全球呼吸系统疾病盛行率不断上升的推动。近几十年来，由于污染水平上升、生活方式改变和人口老化，气喘和慢性阻塞性肺病的发生率急剧上升。根据世界卫生组织的资料，目前约有3亿人患有气喘，超过2亿人患有慢性阻塞性肺病。早期诊断和有效吸入疗法改善了这些疾病的治疗前景。低收入国家认知度较低以及一些国家品牌药品价格高可能会阻碍市场成长。然而，透过研究和开发新型呼吸药物、将数位技术融入设备以及开发结合不同类型吸入器特性的混合吸入器​​，可以克服这些挑战，使患者能够负担得起、更方便地获得有效治疗。

研究的主要特点

本报告对全球呼吸吸入器市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设基准年为 2024 年。

它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球呼吸吸入器市场的主要企业概况。

研究涉及的主要企业包括葛兰素史克、默克、勃林格殷格翰、阿斯特捷利康、3M、Teva Pharmaceutical 和 Sunovion Pharmaceuticals。

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球呼吸吸入器市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。

相关人员可以透过全球呼吸吸入器市场分析中使用的各种策略矩阵来促进他们的决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球呼吸吸入器市场-冠状病毒（COVID-19）大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020-2032 年全球呼吸吸入器市场（按类型划分）（十亿美元）

• 介绍
• 手动操作
• 数位化营运

6. 2020-2032 年全球呼吸吸入器市场（按产品划分）（十亿美元）

• 介绍
• 干粉吸入器
• 定量吸入器
• 其他的

7. 2020 年至 2032 年全球呼吸吸入器市场（按应用划分）（十亿美元）

• 介绍
• 气喘
• 慢性阻塞性肺病(COPD)
• 动脉高血压
• 其他的

8. 2020-2032 年全球呼吸吸入器市场（按最终用户划分）（十亿美元）

• 介绍
• 医院诊所
• 呼吸护理中心
• 学术研究所
• 其他的

9. 2020-2032 年全球呼吸吸入器市场（按地区划分）（十亿美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第十章 竞争格局

• 公司简介
  • Koninklijke Philips NV
  • General Electric Healthcare
  • ResMed Inc.
  • Fisher &Paykel Healthcare
  • Medtronic
  • Boehringer Ingelheim
  • GlaxoSmithKline plc
  • AstraZeneca
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Roche Holding AG
  • Johnson & Johnson
  • Sanofi SA
  • Merck & Co., Inc.
  • Hoffmann-La Roche Ltd
  • Otsuka Pharmaceutical Co., Ltd.
  • Cipla Limited

第 11 章 分析师建议

• 兴衰
• 一致的机会地图

第 12 章参考文献与调查方法

• 参考
• 调查方法

Global Respiratory Inhalers Market is estimated to be valued at USD 35.10 Bn in 2025 and is expected to reach USD 52.81 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.0% from 2025 to 2032.

Figure. Respiratory Inhalers Market Share (%), By Region 2025

Respiratory inhalers are medical devices used for administration of drugs to treat respiratory diseases like asthma and COPD. These help to deliver the required dosage of medication directly to the airways through inhalation. Rising prevalence of respiratory diseases due to environmental factors, growing geriatric population susceptible to such conditions, and increasing awareness about inhaler therapies can drive the market growth. Advancements in inhaler drug delivery technologies, development of smart and digital inhalers, and introduction of combo inhalers with improved efficacy can also drive the market growth. However, high treatment costs and lack of availability in rural regions may hamper its widespread adoption.

Market Dynamics:

Global respiratory inhalers market growth is primarily driven by growing prevalence of respiratory diseases worldwide. Asthma and COPD incidence has increased dramatically in recent decades due to rising pollution levels, changing lifestyle trends, and aging population. As per data from WHO, around 300 million people currently suffer from asthma while over 200 million have COPD. Early diagnosis and availability of effective inhaler therapies have improved the treatment outlook of these conditions. Lack of awareness in low-income nations and high costs of branded drugs in some countries can hamper the market growth. However, ongoing R&D into newer categories of respiratory medicines, integration of digital technology into devices, and development of hybrid inhalers combining attributes of different types of inhalers can overcome these challenges by making effective treatment more affordable and accessible to patients.

Key Features of the Study:

This report provides in-depth analysis of the global respiratory inhalers market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global respiratory inhalers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GlaxoSmithKline, Merck, Boehringer Ingelheim, AstraZeneca, 3M, Teva Pharmaceutical, and Sunovion Pharmaceuticals

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global respiratory inhalers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global respiratory inhalers market

Detailed Segmentation-

• By Type
  • Manually Operated
  • Digitally Operated
• By Product
  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Others
• By Application
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Arterial Hypertension
  • Other
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Koninklijke Philips N.V.
  • General Electric Healthcare
  • ResMed Inc.
  • Fisher & Paykel Healthcare
  • Medtronic
  • Boehringer Ingelheim
  • GlaxoSmithKline plc
  • AstraZeneca
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Roche Holding AG
  • Johnson & Johnson
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Hoffmann-La Roche Ltd
  • Otsuka Pharmaceutical Co., Ltd.
  • Cipla Limited

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Product
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Respiratory Inhalers Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Respiratory Inhalers Market, By Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Manually Operated
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Digitally Operated
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Respiratory Inhalers Market, By Product, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Dry Powder Inhaler
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Metered Dose Inhaler
  • Mammography
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Respiratory Inhalers Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Asthma
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic Obstructive Pulmonary Disease (COPD)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Arterial Hypertension
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Respiratory Inhalers Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Respiratory Care Center
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Respiratory Inhalers Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profiles
  • Koninklijke Philips N.V.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • General Electric Healthcare
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • ResMed Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fisher & Paykel Healthcare
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GlaxoSmithKline plc
  • AstraZeneca
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Roche Holding AG
  • Johnson & Johnson
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Hoffmann-La Roche Ltd
  • Otsuka Pharmaceutical Co., Ltd.
  • Cipla Limited

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"